meet the founder and CEO

---

 Dr. Khachaturian has been the CTO of Wellvii since Oct of 2016 where he leads the R&D of connected vital sign measurement technologies, specifically finger-based blood pressure, pre-diabetic (e.g., vascular stiffness), and glucose sensors.  

He was previously the VP of R&D at ABT Molecular Imaging where he led the development of a compact automated radiopharmaceutical production system for F-18 and C-11 based radiopharmaceuticals. Prior to ABT,  Dr. Khachaturian was the Lead System Designer at GE Healthcare, where he led of the design and manufacture of the Signa® PET/MRI system and lead the design of the Discovery MR750w, a wide bore 3 Tesla imaging system. 

Dr. Khachaturian received his PhD in Nuclear Science and Engineering from Massachusetts Institute of Technology with a focus on medical physics and medical imaging. Dr. Khachaturian has been the inventor on more than 50 patents.